PDGFB and Hepatic fibrosis: A follow-up study demonstrated that miR-483 overexpression in CCl4-injured mouse livers inhibited liver fibrosis, with both miR-483-5p and miR-483-3p having anti-fibrotic activities that, respectively, targeted PDGF-β and TIMP2 [41].